Curriculum Vitae -...
Transcript of Curriculum Vitae -...
1
Curriculum Vitae ----------------------------------
PERSONAL INFORMATION:
Surname: Naseripour
First name: Masood
Title: MD
WORK ADDRESS:
Rassoul Akram Hospital, Niayesh Street,
Sattar-khan Street.
Tehran, Iran
Phone: +982166509162
Academic degree: Professor
The University / Department:
Ophthalmology Department / Iran University of Medical Sciences / Tehran / Iran
Phone number: +98-21-66509162
Fax: + 98-21-66509162
E-mail: [email protected]
2
Education:
1983–1989 School of Medicine/ Tabriz University of Medical Sciences, Doctor of Medicine
Tabriz, Iran
1989–1992 School of Medicine/ Tabriz University of Medical Sciences,
Ophthalmology, Tabriz, Iran
1993–1995 School of Medicine/ Iran University of Medical Sciences, Vitreoretinal
surgery, Tehran, Iran
2000–2001 Wills Eye Hospital, ocular oncology, Philadelphia, USA
Work Experience:
Ophthalmologist / Member of Faculty/ Ophthalmology Department / Kermanshah
University of Medical Sciences / 1995 – 2000
Head of Ophthalmology Department / Kermanshah University of Medical Sciences /
1996 – 1997
Deputy for Education and Research/ Kermanshah University of Medical Sciences /
1997 – 2000
Secretary of Iranian Council for Graduate Medical Education 2001-2004
Ophthalmologist / Member of Faculty /Ophthalmology Department / Iran University of
Medical Sciences / 2001 – up to now
Head of Ophthalmology Department / Iran University of Medical Sciences / 2005 –
2007
Member of Board of Trustee/ Kermanshah University of Medical Sciences / 2004 – 2008
Head of IUMS Eye Research Center 2003-2010
Director of Ophthalmology Department / Iran University of Medical Sciences/
Executive Director the18th, 22nd, 23rd
, 24th
, 25th Annual Congress of the Iranian
Society of Ophthalmology
Dean / Medical School / Iran University of Medical Sciences/ 2014- 2017
Chancellor/ Iran University of Medical Sciences/2017- Up to now
Member of Iranian board of ophthalmology 2015 - Up to now
Director of Iranian board of ophthalmology 2016 - Up to now
3
SCIENTIFIC POSITIONS
1. Professor, Director of Ocular Oncology unit, Eye Department, Rassoul Akram Hospital, Iran
University of Medical Sciences, Tehran, Iran.
2. Scientific Member, Iranian Retina Society, Tehran, Iran, since 2001.
3. Scientific Reviewer for the journal of “ BINA”, Iranian Eye Bank journal, Iran, since 2002.
4. Scientific Reviewer for the journal of “ Ir J Ophthalmology”, journal of the Iranian Society Of
Ophthalmology, Iran, since 2002.
5. Scientific Reviewer for the journal of “ Behbood”, Kermanshah University of medical sciences ,
since 1998.
6. Editorial Board for the journal of “ Ir J Ophthalmology”, journal of the Iranian Society Of
Ophthalmology, Iran, since 2005.
7. Editorial Board for the journal of “ Behbood”, Kermanshah University of medical sciences ,
since 1998.
8. Editorial Board for the journal of “ Medical Education”, Shahid Beheshti University of medical
sciences , since 2003
9. Scientific Reviewer for the journal of “ Saudi Journal of Ophthalmology”, Saudi Arabia since
2010
10. Scientific Reviewer for the journal of “Middle East African Journal of Ophthalmology”,
Middle East African Council of Ophthalmology2012
11. Ocular Oncology program Moderator, World Ophthalmology Congress WOC 2012, Abu-
Dahbi, UAE
12. Scientific Director , Controversies in ophthalmology .Eye Research Center,Rassoul
Akram Hospital,Iran Unversity of Medical Sciences. 3-5 jul 2013
13. Ocular Oncology program Moderator, World Ophthalmology Congress WOC 2014,
Tokyo, Japan
14. Invited Chair, Ocular Oncology program, World Ophthalmology Congress WOC
2014, Tokyo, Japan
15. Scientific Director , the 25th Annual Congress of the Iranian Society of Ophthalmology
16. Head of the Iranian Society of Ophthalmology IrSO International Affairs 2013 -2015
4
17. Ocular Oncology program Moderator, World Ophthalmology Congress WOC 2016,
Guadalajara, Mexico
18. Invited Chair, Imaging in Ocular and Orbital Tumors, World Ophthalmology Congress
2016 (WOC2016), February 5-9, 2016 , Guadalajara, Mexico
5
Publications:
A: Articles
1) Naseripour M, Parvaresh MM. Predisposing factors of Retinal Detachment and Prophylactic
Treatment. Iranian Ophthalmology journal of bina 1996; 1( 4): 47-64
2) Naseripour M, Parvaresh MM. Prophylactic Laser Treatment in Patients with Symptomatic
Retinal Breaks. Bina J Ophthalmol 1999; 4(2):128-133
3) Naseripour M, Parvaresh MM. Scleral buckling Result and Related Risk factors. Iranian
Ophthalmology journal of bina 1999; vol 4(4): 335-340
4) Naseripour M, Iranfar S. Evaluation of Educational Activities of the Faculty of Kermanshah
University of Medical Sciences from medical student’s Standpoint. Iranian journal of Behbood
2000; vol 4( 3): 27-32
5) Naseripour M, Shields CL, Shields J, Guyer DR. Pseudohypopyon of Orange Pigment
Overlying a Stable Choroidal Nevus. Am j Ophthalmol 2001; 132: 416-417.
6) Shields CL, Naseripour M, Shields J. Topical Mitomycin C for Extensive Recurrent
Conjunctival-Corneal Squamous Cell Carcinoma. Am j Ophthalmol 2002; 133: 601-606.
7) Mirzazadeh A, Tavakoli S, Naseripoor M. Comparison of Graduate Medical Education in Iran
with WFME International Guidelines: Quality Improvement in Postgraduate Medical Education.
Iranian Journal of Medical Education. No. 8, 2002. 37-38.
8) Shields J, Shields CL, Naseripour M, Eagle RC, Miller J. Choroidal Melanoma in a Black
Patient with Oculodermal Melanocytosis. Retina 2002; 22: 126-128
6
9) Shields CL, Naseripour M, Shields J, Eagle RC. Topical Mitomycin C for Pagetoid Invasion
of the Conjunctiva by Eyelid Sebaceous Gland Carcinoma. Ophthalmology 2002; 109: 2129-
2133.
10) Shields CL, Naseripour M, Cater J, Shields J, Demirci H, Youseff A, Freire J. Plaque
Radiotherapy for Large Posterior Uveal Melanomas in 354 Consecutive Patients.
Ophthalmology 2002; 109: 1838-1849.
11) Shields CL, Naseripour M, Shields J, Freire J, Cater J. Custom-Designed Plaque
Radiotherapy for Nonresectable Iris Melanoma in 38 Patients: Tumor Control and Ocular
Complications. Am J Ophtalmol 2003; 135: 648- 656.
12) Panda, A., Bajaj, M.S., Balasubramanya, R., Prakash, G., Shields, C.L., Naseripour, M., Shields,
J.A.
Topical mitomycin C for conjunctival-corneal squamous cell carcinoma [1] (multiple letters)
(2003) American Journal of Ophthalmology, 135 (1), pp. 122-124.
13) Naseripour M, Parvaresh MM, Bakhtiari P, Afsar N. Transpupillary Thermotherapy for
Treatment of Occult Subfoveal Choroidal Neovascularization in Age Related Macular
Degeneration. Iranian J Ophthalmol 2004; 17(3):49-57.
14) Mirzadeh A, Hashemi H, Naseripour M, Fotouhi A, Yazdani K, Tavakoli S, Raisi B, Taj M.
Establishment of New Evaluation and Accrediation System for Graduate Medical Education in
Iran. Journal of Medical Education summer 2004; 5(2):69-73.
15) Naseripour M, Bakhtiari P, Mogadam AZ, Vosogh P, Naseripour Majid, Salimi S. Combined
chemoreduction and adjuvant therapy to control advanced retinoblastoma. Iranian Journal of
Ophthalmology 2005; 18(4.): 91-98.
7
16) Naseripour M. Retinoblastoma. Iranian Journal of Ophthalmology 2006; 19(1.): 35-48.
17) Naseripour M, Ansari MR, Sheikhi F, Danesghgar F, Omidian J, Ghaderi E.
Retinopathy Prevalence and Its Risk Factors in Diabetics at Kermanshah Diabetes Research
Center (1994-2000). Iranian journal of Behbood 2006; 9(4): 44-51.
18) Naseripour M, Bakhtiari P, Salimi S, Kashkouli MB, Sadeghipour AR. Rubeosis iridis
complicating acquired astrocytoma of solitary optic nerve head; A clinicopathologic case
report. Iranian Journal of Ophthalmology 2006;19:60-64.
19) Sanjari S, Falavarjani GK, Parvaresh MM, Modarres-zadeh M, Naseripour M, Nojomi
M. Vitreopapillary Traction in Non-arteritic Anterior Ischemic Optic Neuropathy. Bina J
Ophthalmol, 2006; 11(3):289-293.
20) Sanjari MS, Falavarjani KG, Parvaresh MM, Modarreszadeh M, Naseripour M, Nojomi
M. Vitreopapillary Traction in Nonarteric Anterior Ischemic Optic Neuropathy. Iranian J
Ophthalmic Res 2006; 1(2): 110-112.
21) Naseripour M, falavarjani KG, Akbarzadeh S. Retinocytoma Associated with Bilateral
Retinoblastoma. Bina J Ophthalmol 2007;1 (13):130-132.
22) Kashkouli MB, Salimi S, Aghaee H, Naseripour M. Bilateral pseudomonas aeruginosa
endophthalmitis following bilateral simultaneous cataract surgery. Indian J Ophthalmol.
2007 sep- oct; 55 (5):374-375.
23) Kashkouli MB, Reaee R, Nilforoushan N, Salimi Sh, Foroutan AR, Naseripour M. Topical
Antiglaucoma Medications and Lacrimal Drainage system obstruction. Ophthal Plast Reconstr
surg 2008; 24 (3):172-5.
8
24) Sadeghipour AR, Abolhasani M, Naseripour M. Association of Vessel Density and Vascular
Endothelial Growth Factor with Local Invasive Growth in Ocular Retinoblastoma,Hazrat
Rasool Akram Hospital 2000-2006. Journal of Iran University of Medical Sciences. 2008; 57
(14): 133-141.
25) Naseripour M, Akbarzadeh S, Ahadian A, Vosough P. The Role of periocular
carboplatin in treatment of advanced intraocular retinoblastoma. Iran J Ophthalmol 2008;
20(1):16-19.
26) Kashkouli MB, Salimi S, Bakhtiari P, Parvaresh MP, Sanjari MS, Naseripour M. EMLA
Cream Application without Occlusive Dressing Before upper facial Botulinum Toxin
Injection. A Randomized Double-Blind Placebo-Controlled Trial. Annals of plastic Surgery
Volume 60, Number 4, April 2008; 353-356.
27) Naseripour M, Nazari H, Bakhtiari P, Modarreszadeh M, Vosough P, Ansari M.R, Ahadian
A. Outcomes and Prognosis of Treatment for Retinoblastoma with Primary Chemotherapy and
Focal Treatment . Bina J Ophthalmol 2008; 14(1): 3-9.
28) Moderreszadeh M, Naseripour M, Falavarjani KG, Nikeghbali A, Hashemi M, Paravaresh
MM. Two Different Doses of Intravitreal Bevacizumab for Treatment of Choroidal
Neovascularization Associated with Age Related Macular Degeneration . J Ophthalmic Vis Res
2008; 3(2): 102-107.
29) Naseripour M, Nikeghbali A, Vadipour A, Bakhtiari P, Ahadian A. Combined Tranpupillary
thermotherapy with subtenon triamcinolone injection in treatment of choroidal
neovasculariaztion secondary to exudative age related macular degeneration. Armaghane danesh
J 2008; 13 (1): 1-13.
9
30) Naseripour M, Kashkouli MB, Jaberi MS, Aghaee GH, Ahadian A. Plaque Radiotherapy in
Recurrent or Incomplete-Excised Conjunctival Squamous Cell Carcinoma and Melanoma.
Iranian J Ophthalmol 2008; 20 (3): 19-23.
31) Naseripour M, Nazari H, Bakhtiari P, Modareszadeh M, Vosough P, Ansari MR, Ahadian A.
Outcomes and prognosis of treatment for retinoblastoma with primary chemotherapy and focal
treatment. Bina J ophthalmology 2008, 14 (1):3-9.
32) Naseripour M, Nazari H, Bakhtiari P, Modarres M, Vosough P, Ausari M. Retinoblastoma in
Iran: outcomes in terms of patients' survival and globe survival. (2009) Br J ophthalmol. Jan; 93
(1):28-32.
33) Naseripour M, Akbarzadeh S, Bakhtiari P, Ahadian A. Adjuvant Effects of Periocular
Chemotherapy in Treatment of Advanced Intraocular Retinoblastoma. Journal of Iran
University of Medical Sciences 2008 . 62(16)187-193
34) Modares-zadeh M. Naseripour M, Falavarjani KG, Nikeghbali A, Hashemi M, Parvaresh
MM. Intravitreal Injection of 2.5 mg VERSUS 1.25 mg Bevacizumab (Avastin) for
Treatment of Choroidal Neovascularization(CNV) Associated with Age-related Macular
Degeneration (AMD). Retina 2009 mar; 29(3): 319-24.
35) Naseripour M, Falavarjani KG, Mirfallah K, Begheri SR. Photodynamic therapy for
vasoproliferative tumors and capillary hemangiomas of retina. Bina J Ophthalmol 2009;
14(2): 109-115.
، محمد رضا سریه، پورمسعود ناصری ،هاویه محمد رضا، صدیقه مزجاوه حجاسی، محمد علی عقابیان، علیزضا احمدیان (63
خلیل قاسمی فالورجاوی، حسیه وظزی. اوداسه گیزی مساحت عزوق تاسه تشکیل شده واشی اس بیماری استحاله وابسته به سه
(، پاییش و 22،22، پیاپی )2شماره 5ماکوال با استفاده اس روش آستاوه گذاری اتسو تغییز یافته. مجله فیشیک پششکی ایزان، دوره
.78سمستان
10
37) Nazari H, Modarreszadeh M, Kashkouli MB, Naseripour M, Parvaresh MM, Nazari P. Central
retinal artery perfusion following 0.1 ml intravitreal injection of Bevacizumab. Iran J
Ophthalmol 2009;21(2):13-18.
38) Naseripour M, Nazari H, Bakhtiari P, Ahadian A, Jaberi R. Ruthenium 106 Plaque for retinal
vasoproliferative tumors. Iran J Ophthalmol 2009;21(2):31-35.
39) Saadat S, Naseripour M, Rahimi B. Safety preparedness of urban community for new year
fireworks in tehran. In press BURNS. Burns 35(2009) 719-722.
40) Modarres M, Nazari H, Falavarjani KG, Naseripour M, Hashemi M, Parvaresh MM.
Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic
retinopathy. Eur J Ophthalmol 2009; 19: 848-852.
41) Naseripour M, Falavarjani GH, Oladi MR, Modarre M. Testing Toxicity of Intravitreal
Bevacizumab (Avastin) used for the Treatment of Choroidal Neovascularization
Associated with Age-Related Macular Degeneration: A Full Field ERG Study. Iranian
Journal of Ophthalmology 2009;21(3):49-55
42) Falavarjani KG, Nikeghbali A, Modarreszadeh M, Hashemi M, Parvaresh MM,
Naseripour M. Longterm Results of Fixation of Dislocated Intra Ocular Lenses Using
Hoptic Externalization Through a Clear Corneal Incision. No 63 vol 16 Journal of Iran
University of Medical Sciences 2009.
43) Naseripour M, Falavarjani KG, Bakhtiari P, Vosough P, Aryad F. Retinoblastoma
survival in iran 10 tears experience of a referral center. Iranian Journal of Ophthalmology
2009;21(4):17-24.
11
2010
44) Saadat S, Naseripour M, Smith GA. The health and economic impact of fireworks-related
injuries in Iran: a household survey following the New Year's Festival in Tehran. Injury. 2010
Jul;41(7):e28-33.
45) Naseripour M, Falavarjani KG, Akbarzadeh S. Retinocytoma associated with bilateral
retinoblastoma. Indian J Ophthalmol. 2010 Mar-Apr;58(2):155-156.
46) Saadat S, Naseripour M, Karbakhsh M, Rahimi Movaghar V. Perceived risk and risk-
taking behavior during the festival firework. Am J Health Behav. 2010;34(5): 525-531.
47) Falavarjani KG, Modarres M, Nazari H, Naseripour M, Parvaresh MM. Diabetic macular
edema following panretinal photocoagulation. Arch Ophthalmol. 2010 Feb;128(2):262;
48) Falavarjani KG, Mohammadreza H, Marjaneh Hejazi S, Naseripour M. A Modified
Semiautomatic Method for Measurement of Hyperfluorescence Area in Fluorescein
Angiography. Iranian Journal of Ophthalmology 2010;22(4):73-79 .
49) Saadat S, Naseripour M, Karbakhsh M, Rahimi-Movaghar V. Perceived risk and risk-
taking behavior during the festival firework. Am J Health Behav. 2010 Sep-Oct;34(5):525-
531.
50) Falavarjani KG, Naseripour M. New hope for retinoblastoma patients. J Ophthalmic Vis Res.
2010 Jul;5(3):213-4.
51) Falavarjani KG, Modarres M, Nazari H, Naseripour M, Parvaresh MM. Diabetic macular
edema following panretinal photocoagulation. Arch Ophthalmol. 2010 Feb;128(2):262;
12
2011
52) Samiy N, Harandi ZA, Naseripour M, Lai TY. Bilateral elevated macular lesions. J
Ophthalmic Vis Res. 2011 Jan;6(1):55-62.
2012
53) Naseripour M, Retinoblastoma survival disparity’’: The expanding horizon in developing
countries. Saudi J of ophthalmology (2012) 26, 157-161.
54) Kashkouli MB, Heirati A, Pakdel F, Kiavash V, Naseripour M, Aghamohammadi F. Long-
term follow-up of invasive ocular surface squamous cell carcinoma treated with excision,
cryotherapy, and topical mitomycin C. (2012) Graefe's Archive for Clinical and Experimental
Ophthalmology, 250 (10), pp. 1527-1532.
2013
55) Saliminejad, K., Behnam, B., Akbari, M.T., Khorshid, H.R.K., Ghassemi, F., Amoli, F.A.,
Akhondi, M.M., Vosoogh, P., Naseripour, M., Ahani, A. Rapid detection of RB1 recurrent
mutations in retinoblastoma by ARMS-PCR. (2013) Journal of Genetics, pp. 1-5. Article in
Press.
56) Falavarjani, K.G., Modarres, M., Hashemi, M., Parvaresh, M.M., Naseripour, M., Zare-
Moghaddam, A., Nekoozadeh, S. Incidence of acute endophthalmitis after intravitreal
bevacizumab injection in a single clinical center. (2013) Retina, 33 (5), pp. 971-974.
57) Ahani, A., Akbari, M.T., Saliminejad, K., Behnam, B., Akhondi, M.M., Vosoogh, P.,
Ghassemi, F., Naseripour, M., Bahoush, G., Khorshid, H.R.K. Screening for large
rearrangements of the RB1 gene in Iranian patients with retinoblastoma using multiplex
ligation-dependent probe amplification. (2013) Molecular Vision, 19, pp. 454-462.
58) Khalil Ghasemi Falavarjani, Masih Hashemi, Mehdi Modarres, Mohammad Mehdi Parvaresh,
13
Masood Naseripour, Hossein Nazari, Ali Jalili Fazel. Vitrectomy for Posterior Segment
Intraocular Foreign Bodies, Visual and Anatomical Outcomes. Middle East African Journal of
Ophthalmology, Volume 20, Number 3, July - September 2013
2014
59) Kord Valeshabad A, Naseripour M, Asghari R, Parhizgar SH, Parhizgar SE, Taghvaei M5,
Miri S. Enucleation and evisceration: indications, complications and clinicopathological
correlations. Int J Ophthalmol. 2014 Aug 18;7(4):677-80.
2015
60) Falavarjani KG, Aghamirsalim M, Modarres M, Hadavandkhani A, Hashemi M, Parvaresh
MM, Naseripour M, Samiy N . Endophthalmitis after resident-performed intravitreal
bevacizumab injection. Can J Ophthalmol. 2015 Feb;50(1):33-6.
61) Ghasemi Falavarjani K, Alemzadeh SA, Modarres M, Parvaresh MM, Hashemi M,
Naseripour M, Nazari Khanamiri H, Askari S. Scleral buckling surgery for rhegmatogenous
retinal detachment with subretinal proliferation. Eye (Lond). 2015 Apr;29(4):509-14.
62) Masood Naseripour, Mitra Mehrazma, Rama Pourmatin, Mohsen Bahmani Kashkouli, Ahad
Sedaghat, Elmira Gheytanchi. Monosomy 3 by chromogenic in situ hybridization (CISH) in
Iranian patients with uveal melanoma, Journal of Current Ophthalmology, 2015, 27 ( 1-2 ): 41
- 4
63) Naseripour M, Ghasempour A, Falavarjani KG, Sanjari MS, Yousefi M. Perfluorocarbon
liquid migration into the subarachnoid space in a patient with morning glory syndrome. J Curr
Ophthalmol. 2015 Oct 28;27(1-2):60-2.
14
2016
64) Masood Naseripour, Ramin Jaberi, Ahad Sedaghat, Zohreh Azma, Marzieh Nojomi, Khalil
Ghasemi Falavarjani, Hossein Nazari. Ruthenium-106 brachytherapy for thick uveal
melanoma: reappraisal of apex and base dose radiation and dose rate, J Contemp
Brachytherapy 2016; 8, 1: 66–73
65) M Naseripour, H Aghaei, A Sedaghat, A Kheirkhah, R Jaberi , Z Azma . Corneal Patch Graft:
A New Approach for Scleral Necrosis Secondary to Plaque Radiotherapy Cornea. 2016
Apr;35(4):565-8.
66) Masood Naseripour, Khalil Ghasemi Falavarjani, Ahad Sedaghat,Arezoo Karimi
Moghaddam, Sadaf Nasserisina, Sayyed Amirpooya Alemzadeh. Half‑dose Photodynamic
Therapy for Chronic Central Serous Chorioretinopathy. J Ophthalmic Vis Res 2016; 11 (1): 66‑
69.
2017
67) Ghasemi Falavarjani K, Alemzadeh SA, Modarres M, Alemzadeh SA, Parvarash MM,
Naseripour M, Hashemi M, Robatmeili M. Outcome of surgery in patients with giant retinal
tear: 10 years experience.Eye (Lond). 2017 Aug 4. [Epub ahead of print]
68) Naseripour M, Hamidian R, Smith GA, Saadat S. Effectiveness of Educational Interventions
on Fireworks-related Injuries among Schoolboys. Am J Health Behav. 2017 May 1;41(3):223-
227.
69) Naseripour M, Maleki A, Astaraki A, Sedaghat A, Jaberi R, Lee S, Azma Z, Silpa-Archa S.
RUTHENIUM-106 BRACHYTHERAPY IN THE TREATMENT OF CIRCUMSCRIBED
CHOROIDAL HEMANGIOMA. Retina. 2017 Mar 23. [Epub ahead of print]
15
70) Shahraki K, Ahani A, Sharma P, Faranoush M, Bahoush G, Torktaz I, Gahl WA, Naseripour
M, Behnam B. Genetic screening in Iranian patients with retinoblastoma. Eye (Lond). 2017
Apr;31(4):620-627. doi: 10.1038/eye.2016.289. Epub 2016 Dec 16.
71) Hedayatfar A, Falavarjani KG, Soheilian M, Elmi Sadr N, Modarres M, Parvaresh MM,
Naseripour M, Rohani M, Almasi M, Chee SP. Mycophenolate Mofetil for the Treatment of
Multiple Sclerosis-associated Uveitis. Ocul Immunol Inflamm. 2017 Jun;25(3):308-314. Epub
2016 Jul 5.
2018
72) Dehdashtian E1, Mehrzadi S
2, Yousefi B
3, Hosseinzadeh A
4, Reiter RJ
5, Safa M
6, Ghaznavi H
7,
Naseripour M8. Diabetic retinopathy pathogenesis and the ameliorating effects of melatonin;
involvement of autophagy, inflammation and oxidative stress. Life Sci. 2018 Jan 15;193:20-
33.
73) Ilka R1, Mohseni M
2, Kianirad M
3, Naseripour M
4, Ashtari K
5, Mehravi B
6. Nanogel-based
natural polymers as smart carriers for the controlled delivery of Timolol Maleate through the
cornea for glaucoma. Int J Biol Macromol. 2018 Apr 1;109:955-962.
16
B: Books
1 - MasoodNaseripourand ArunD.Singh ,Retinoblstoma:Enucleation Chapter in” Pocket
Guild to Ocular Oncology and Pathology”by Hans E.Grossniklaus.Springer Heidelberg
New York Dordrecht London ISBN 978-3-642-28911-8,2012.
2- Naseripour Masood, "Clinical Ophthalmic Oncology”, Second Edition, Chapter 23
"Uveal Vascular Tumors” . Springer-Verlag Berlin Heidelberg 2014. DOI 10.1007/978-3-
642-54255-8_23
17
RESEARCH PROJECTS:
1. Congenital Cataract Incidence in Tabriz 1992
2 Diabetic Retinopathy Cumulative Incidence Rate and Related Risk factors in "Diabetic Research
Center" patients. 1993
3. Efficacy of Argon laser Trabeculoplasty in Primary Open Angle Glaucoma. 1995
4. Epidemiological Study of Diabetic retinopathy and risk factors since Diagnosis in diabetic
patients of Kermanshah Diabetic Research center. 1999
5. Health and Diseases Evaluation in Community Based Medical Education Field in Kermanshah
1999
6. Efficacy of Transpupillary Thermotherapy for Occult Sub-foveal CNV. 2003
7. Efficacy of Sub threshold Grid Laser photocoagulation in Patients with symptomatic 2003
8 The Determination of prevalence of eye related macular degeneration in population after than 40
years old in Kermanshah province in 2005
9. Macular thickness and retinal nerve fiber layer thickness evaluation following brachytherapy of
intra-ocular tumors. 2004
10. Combined chemoneduction and periocular carboplatin in treatment of advanced retinoblastoma.
2004
11. The evaluation of the results of ruthenium 106 plaque radiotherapy for the treatment of
intraocular choroidal malignant melanoma. 2005
18
12. Comparison of different dose (1.25 and 2.5mg) of intravitreal Bevacizumab (Avastin) with
combined intravitreal Avastin (1.25 mg) and Triamcinolon (2 mg) in exudative age-related macular
degeneration. A double-blind clinical trial. 2005
13. The investigation of outcomes and prognosis of patients with Retinoblastoma following primary
chemoreduction and focal treatment based on International (A-E) classification 2006.
14. Electrophysiologic findings (GERG) after interavitreal Avastin (Bevacizumab) treatment in
choroidal neovascular membrane. 2007
15. The evaluation of the Photodynamic therapy for retinal vascular tumors of retina. 2008
16. Designing and development of a calculating system to measure the hyperfleurecent areas in
retinal angiography. 2008
17. Investigation of Sandwichtherapy for Choroidal Melanoma
18. Comparative study of disease–free ratio in the patients with uvula melanoma and monosomy-3
with and without adjuvant therapy (temozolamid and peginterferon α-2b). 2008
19. The evaluation of the results of primary transpupillary thermotherapy in posterior pole small
choroidal melanomas. 2008
20. Detection of Mutations in total exon and promotor of the Rb1 gene in hazrate rasol hospital
retinoblastoma patients by using exon by exon PCR-SSCP analysis. 2008
21. Incidence rate of injuries due to fire work at last Wednesday of solar year in Tehran. 2005
19
22. Mutation profiling of RB1 gene in patients with retinoblastoma . 2009
23. Photodynamic therapy for retinal vasoproliferative and angiomatous tumors of retina. 2008
24. Frequency of Monosomy-3 in patients with uveal melanoma according to Chromosome in
situ hybridization in patients attending to in Rasoul Akram Hospital from 2003 to 2013 . 2011
25. Preparation and In Vivo Evaluation of Nanoliposomes containing Melphalan after Intravitreal
Administration . 2011
یهربط ب تهر شبک یا در داد ریدهتغ یهف یدجول ا ىیهذل رگرض یریب کارگ. دکتر هطعد اصری پر -62
چشن
با اضتفاد از هذل یو پاراهتري كاكص چذ بالضتهایچشن کدکاى هبتال ب رت یبقا لیتحل. دکتر هطعد اصری پر -62
حالت
بالضتهایچشن کدکاى هبتال ب رت یبقا لیدر تحل یکاربرد هذل شکذگدکتر هطعد اصری پر. -62
20
Conference Presentations:
1) Deep Vitrectomy Result in Patients with Active PDR.
4th
National Ophthalmologic seminar, Tehran, Iran 1994
2) Episcleral Balloon in Patients with Retinal Detachment.
5th
Ophthalmology Congress, Tehran, Dec. 1995
3) Retinal Detachment Management by Episcleral Parabulbar Balloon. The First Report from Iran
The First International Ophthalmology Congress, Tehran-Iran, 1995
4) Prognostic Factors in Intraocular Foreign Bodies.
7th
Iranian Ophthalmologic Congress, Isfahan, Iran 1997
5) Results of Prophylactic Laser therapy in retinal detachment.
8th
Ophthalmologic Congress, Tehran, Iran 1998
6) Scleral buckling Result and Prognostic Factors.
8th
Ophthalmologic seminar, Tehran, Iran 1998
7) New in Retinoblastoma.
Second International Ophthalmology Congress, Tehran-Iran, 2001
8) Management of Choroidal Malignant Melanoma.
2nd
International Ophthalmology Congress, Tehran, Iran, 2001
9) Health and Diseases Status in Aged People in Community Oriented Medical Education Field in
Kermanshah.
2nd
Health and Preventive Medicine Seminar, Kermanshah, Iran, 2001.
21
10) Prevalence of Abnormal Red Reflex in Community Based Medical Education Field in
Kermanshah. Kermanshah, Dec. 2001
11) Retinoblastoma: Early Diagnosis or Presenting Symptoms Education?
23rd Congress of advances in Pediatric, Tehran, May 2002
12) Evaluation of Patients with Intraocular Tumor.
Tehran, Iran, Feb 2002.
13) Analytic Comparison of New Accreditation System for Graduate.
Medical Education in Iran with ACGME and RCPSC Ahwaz, 2002
14) How to Approach to a Patient with Intraocular Tumor.
Shahid Beheshti UMS. Tehran, Feb 2002.
15) Transpupillary Thermotherapy for Treatment of Occult Choroidal Neovascularization.
13th
Ophthalmology Congress, Tehran, Dec. 2003.
16) Partial Lamellar Sclerouvectomy for Management of ciliary Body tumors.
13th
Ophthalmology Congress, Tehran, Dec. 2003.
17) Transpupillary Thermotherapy for Management of Choroidal Melanoma.
13th
Ophthalmology Congress, Tehran, Dec. 2003
18) Partial Lamellar Sclerouvectomy:A Safe Procedure for Saving the Eyes with Ciliary body
Tumor.
XI International Congress of Ocular Oncology Jan 2004, Hyderabad, India
22
19) Are Combined Chemoreduction and Adjuvant treatment Sufficient to Control the Patients with
Advanced Retinoblastoma?
XI International Congress of Ocular Oncology Jan 2004, Hyderabad, India
20) Visual Results Following Transpupillry Thermotherapy of Choroidal Neovascularization In
Patients with Exudative ARMD.
4th
EURETINA Congress, Milan, Italy, May 2004.
21) Transpupillary Thermotherapy of Occult and Classic Choroidal Neovascularization in Patients
with Age-Related Macular Degeneration.
Naseripour M, Parvaresh M.M, Bakhtiari P, Afsar N, Dec 2004.
14th Iranian Congress of Ophthalmology 14-17 December 2004 Tehran
22) Ruthenium 106 Plaque Radiotherapy in Intraocular Tumors.
Naseripour M, Tarassoli K, Jaberi R, Samiee F, Dec 2004.
14th Iranian Congress of Ophthalmology 14-17 December 2004 Tehran
23) Combined Chemoreduction and Adjuvant Therapy to Control Retinoblastoma.
Naseripour M, Bakhtiari P, Zare Moghadam A, Vosough P. Dec 2004.
14th Iranian Congress of Ophthalmology 14-17 December 2004 Tehran
24) Optic Disc Astrocytoma Case Report.
Naseripour M, Bakhtiari P, Imani M, Dec 2004.
14th Iranian Congress of Ophthalmology 14-17 December 2004 Tehran
25) Medulloepithelioma of Ciliary Body.
Naseripour M, Bakhtiari P, ZareMoghadam A, Dec 2004
14th Iranian Congress of Ophthalmology 14-17 December 2004 Tehran
23
26) Surgical and Anatomic Outcome of Pars Plana Vitrectomy with Silicon Oil Tamponade without
Buckle Placement for the Treatment of Primary Rhegmatogenous Retinal Detachment
Parvaresh MM, Naseripour M, Bakhtiari P.
20th ASIA Pacific Academy of Ophthalmology Congress
27) Prevalence and Risk Factors of Supra-choroidal Hemorrhage in Scleral Surgery
Bakhtiari P, Parvaresh MM, Naseripour M.
20th ASIA Pacific Academy of Ophthalmology Congress
28) Ruthenim 106 plaque radiotherapy in treatment of choroidal tumor.
Naseripour M, Bakhtiari P, Jaberi R, Kheirkhah R, Samiee F.
International VIIIth Congress of the Pan Arab African Council of Ophthalmology (PAACO) and
the XIIth UAE Ophthalmic Conference April2005 Dubai
29) Combined Chemoreduction and Adjuvant Therapy to Control Retinoblastoma.
Naseripour M, Bakhtiari P, Moghadam A, Vosough P, Nasrabadi M
International VIIIth Congress of the Pan Arab African Council of Ophthalmology (PAACO) and
the XIIth UAE Ophthalmic Conference April 2005 Dubai (P)
30) Optic Nerve Astrocytoma
Naseripour M, Bakhtiari P, Imani M,Sadeghipour.
Ophthalmology (PAACO) and the XIIth UAE Ophthalmic Conference April 2005 Dubai (P)
31) Do We Need Effective Modalities to Control the Patients with Advanced Retinoblastoma?
Naseripour M, P. Bakhtiari, SH. Salimi, P Vosough.
ISGED and IRS 2005 & ICOO 2005 Canada
32) Regression of Advanced Retinoblastoma after Multiple Subconjunctival Carboplatin Injection
Naseripour M, N. Bahrivand, A. Vadipour, P. Bakhtiari
24
ISGED and IRS 2005 & ICOO 2005 Canada
33) Plaque Radiotherapy in Vitrectomized Eye with Recurrent Retinoblastoma
Naseripour M, M Hashemi, R Jaberi, M Almasi Nasrabadi
ISGED and IRS 2005 & ICOO 2005 Canada
34) Transpupillary Thermotherapy (TTT) for Treatment of Idiopathic Choroidal
Neovascularization(o)
Naseripour M, Nikeghbali A, Ariaeetabar H, Bakhtiari P.
15th Iranian Congress of Ophthalmology. 15-18 December 2005 Tehran
35) Brachytherapy Using Ruthenium-106 Plaque for Choroidal Management Methods (O)
Naseripour M, Jaberi R, Bakhtiari P, Kheirkhah A, AliAkbar Navahi R
15th Iranian Congress of Ophthalmology. 15-18 December 2005 Tehran
36) Case-Control Study of Occurrence of Predictors of Anterior Hyaloid Fibro vascular Proliferation
after Diabetic Vitrectomy .
Parvaresh MM, Naseripour M, Bakhtiari P, Khodadoust A
15th Iranian Congress of Ophthalmology 15-18 December 2005 Tehran
37) Intravitreal Triamcinolone Injection for Treatment of Macular Edema Due to BRVO (O)
Hashemi M,Parvaresh MM, Naseripour M, Manshai K
15th Iranian Congress of Ophthalmology. 15-18 December 2005 Tehran
38) Intravitreal Triamcinolone Injection for the Treatment of Macular Edema due to CRVO (O)
Hashemi M, Parvaresh MM, Naseripour M, Manshai K
15th Iranian Congress of Ophthalmology 15-18 December 2005 Tehran
39)Intravitreal Triamcinolone Injection for CSME as Primary Treatment (O)
25
Hashemi M, Parvaresh MM, Naseripour M, Manshai K
15th Iranian Congress of Ophthalmology 15-18 December 2005 Tehran
40) Transpupillary Thermotherapy (TTT) for Treatment of Choroidal Neovascularization due to
Myopia (P)
Naseripour M, Hashemi M, Ariaeetabar H, Bakhtiari P
15th Iranian Congress of Ophthalmology 15-18 December 2005 Tehran
41) Transpupillary Thermotherapy (TTT) for Treatment of
Occult, Classic and Mixed-Type Choroidal Neovascularization (CNV) in Age Related Macular
Degeneration (ARMD) (O)
Naseripour M, Parvaresh MM, Bakhtiari P, Manshai K,Salimi SH
15th Iranian Congress of Ophthalmology 15-18 December 2005 Tehran
42) Transpupillary Thermotherapy (TTT) as primary Treatment or Adjuvant to plaque Radiotherapy
for Choroidal Malignant Melanoma (O).
Naseripour M, Parvaresh MM, Ariaeetabar H, Bakhtiari P
15th Iranian Congress of Ophthalmology 15-18 December 2005 Tehran
43) Do We Need More Effective Modalities to Control the Patients with Advanced Retinoblastoma?
(O) . Naseripour M, Bakhtiari P, ZareMoghadam A, Salimi SH, Vosough P
15th Iranian Congress of Ophthalmology 15-18 December 2005 Tehran
44) Nerve Fiber Layer (NFL) and Macular Thickness Measurment by Optical Coherence
Tomography (OCT) in Emmetropic, High Myopic and High Hyperopic Eyes
Parvaresh MM, Imani M, Naseripour M, Bakhtiari P, Salimi SH
15th Iranian Congress of Ophthalmology 15-18 December 2005 Tehran
45) Ten years Survival Rate Study of Patients with Retinoblastoma in Iran.
26
Naseripour M, P Vosough, F Arian, P Bakhtiari, SH Salimi
Saudi Ophthalmology Congress March 2006
47) Case - Control Study of Occurrence of Predictors of Anterior Hyaloid Fibrovascular
Proliferation Naseripour M, M Parvaresh, P Bakhtiari, A Khodadoust
Saudi Ophthalmology Congress March 2006
48) Brachytherapy Using Ruthenium -106 Plaque for Choroidal Melanoma
Naseripour M, R Jaberi, P Bakhtiari, A Kheirkhah, S Ali
Saudi Ophthalmology Congress March 2006
49. Optical Coherence Tomography (OCT) in Emmetropic, High-Myopic and High- Hyperopic
Eyes.
Naseripour M, M Parvaresh, P Bakhtiari, M Imani, A Kheirkhah
Saudi Ophthalmology Congress March 2006
50. Plaque Brachytherapy in Uveal Melanoma
Ramin Jaberi, Naseripour M, Farhad Samiei
The 3 th National Scientific Congress of IRSA 2005
51. The role of hyperthermia in control of subfoveal CNV: stabilization of CNV with low recurrent
rate.
Naseripour M, Pejman Bakhtiari,
XVI Ophthalmology Congress of Iran , November 2006
52. Evaluation of periocular carboplatin injection combined with chemotherapy for advanced
intraocular retinoblastoma . Naseripour M, Akbarzadeh S, Bakhtiari P, Vosough P, Vadipour A
XVI Ophthalmology Congress of Iran, November 2006
27
53. Efficacy of the Intravitreal Injection of Bevacizumab (Avastin) For Treatment of Wet – Type
ARMD.
Naseripour M, Ansari MR, Modarreszadeh M, Bakhtiari P, Salimi Sh
XVI Ophthalmology Congress of Iran
November 2006
54. Plaque Radiotherapy for ocular surface tumors.
Naseripour M, Ansari MR, Jaberi R, Bakhtiari P, Salimi Sh.
XVI Ophthalmology Congress of Iran November 2006
55. Ten Years Survival Rate Study of Patients with Retinoblastoma In Iran.
Naseripour M, Vosough P, Arian F, Bakhtiari P, Salimi SH.
XVI Ophthalmology Congress of Iran , November 2006
56. The effect of transpupillary thermotherapy with or without Sub – Tenon triamcinolon injection
for the treatment of CNV due to ARMD.
Naseripour M, Vadipour A, Parvaresh MM, Bakhtiari P, Salimi Sh
XVI Ophthalmology Congress of Iran, November 2006
57. High dose versus low dose ruthenium 106 plaque radiotherapy for retinal vasoproliferative
tumors (VPT).
Naseripour M , Bakhtiari P, Jaberi R
ISOO MEETING 2007, International Society of Ocular Oncology, Siena, 26-30 June 2007
58. The prognosis of retinoblastoma in terms of patient’s survival and globe survival
Naseripour M., Bakhtiari P., Ansari M.R., Vosough P.
ISOO MEETING 2007, International Society of Ocular Oncology, Siena, 26-30 June 2007
59. Retinoblastoma: Predictor factors for patients survival
28
Naseripour M., Bakhtiari P., Vosough P., Arian F.
ISOO MEETING 2007, International Society of Ocular Oncology, Siena, 26-30 June 2007
60. Ruthenium 106 plaque radiotherapy for choroidal malignant melanoma: 5 years experience.
Naseripour M, Nazari H, Bakhtiari P, Jaberi R.
ISOO MEETING 2007, International Society of Ocular Oncology, Siena, 26-30 June 2007
61. Visual and anatomical results of brachytherapy in circumscribed choroidal hemangioma.
Naseripour M, Bakhtiari P, Nazari H, Jaberi R
ISOO MEETING 2007, International Society of Ocular Oncology, Siena, 26-30 June 2007
62) High Dose versus Low Dose Ruthenium 106 Plaque Radiotherapy for Retinal Vasoproliferative
Tumors.
Naseripour M, Bakhtiari P, Nazari H, Jaberi R
17th
Iranian Congress of Ophthalmology, Tehran, 4-7 December 2007.
63) Intravitreal Injection of Bevasizumb before Vitrectomy for Proliferative Diabetic Retinopathy;
Modarreszadeh M, Naseripour M.
17th
Iranian Congress of Ophthalmology . Tehran, 4-7 December 2007.
64) Ruthenium 106 Plaque Radiotherapy for Choroidal Malignant Melanoma: 5 Years Experiences.;
Naseripour M, Bakhtiari P, Jaberi R.
17th
Iranian Congress of Ophthalmology. Tehran, 4-7 December 2007.
65) Intravitreal Injection of Bevacizumab for Treatment of Macular Edema after Retinal Vein
Occlusion.
Naseripour M, Modarreszadeh M, Ansari MR, Falavarjani KG.
Middle East African council of ophthalmology . UAE, Dubai. April-March 2007.
29
66) Ruthenium-106 Plaque Radiotherapy for Choroidal Malignant Melanoma: 5 Years Experinces;
Naseripour M, Nazari H, Bakhtiari P, Jaberi R.
4th
Asian Congress of Safe Communities. Thiland, 21-24 November 2007.
67) Bevacizumab and Retinal Ischemia
Naseripour M, MD.
Annual meeting of Retina society. Iran, Zibakenar, 15 May 2008.
68) Age related macular degeneration
Naseripour M, MD.
11th
Annual Optometry Congress, Sep 2007 Tehran, Iran.
68- Current and New pharmacologic treatments of ARMD
Retina and Vitreous Seminar, June 2006 Tehran, Iran.
69- Sarcoidosis presenting as a choroidal tumor.
Auther (s) Nazari H. Naseripour M. (Posters) XVIII Ophthalmology Congress of IRAN. 25-27
Nov 2008.
70- Anti angiogenic therapy with intravitreal bevacizumab for aggressive posterior retinopathy of
prematurity (APROP) unresponsive to conventional laser therapy. Nazari H, Parvaresh MM,
Hashemi M, Modarreszadeh M, Naseripour M, Nikeghbali A. (Free papers) XVIII
Ophthalmology Congress of IRAN. 25-27 Nov 2008.
71- Visual function and predictor factors following brachytherapy for circumscribed choroidal
hemangioma. Naseripour M. (Free papers) XVIII Ophthalmology Congress of IRAN. 25-27
Nov 2008.
30
72- Intravitreal use of bevacizumab (avastin) for choroidal neovascularization associated with age
related macular degeneration; a fuul field ERG study. Naseripour M. (Free papers). XVIII
Ophthalmology Congress of IRAN. 25-27 Nov 2008.
73- Photodynamic therapy in retinal angiomatosis proliferations. Naseripour M. (Free papers).
XVIII Ophthalmology Congress of IRAN. 25-27 Nov 2008.
74- Primary transpupillary thermotherapy for small choridal melanoma. Naseripour M. (Free
papers). XVIII Ophthalmology Congress of IRAN. 25-27 Nov 2008.
75- Ruthenium brachythrapy for retinoblastoma. Naseripour M. (Free papers). XVIII
Ophthalmology Congress of IRAN. 25-27 Nov 2008.
76- When to continue or to discontinue Avastin in exudative ARMD. Naseripour M
6-8 March 2009, Tehran Razi Convention Center.
77- Pharmacotherapy for retinal capillary hemangioma, vasoproliferative tumors and coat` disease.
Naseripour M.
6-8 March 2009, Tehran Razi Convention Center.
78- When to countinue or to descountinue Avastin in exudative ARMD. 6-8 March.
Naseripour M. 2009, Tehran Razi Convention Center.
79- Pharmacotherapy for retinal capillary hemangioma, vasoproliferative tumors and coat` disease.
Naseripour M. 6-8 March 2009, Tehran Razi Convention Center.
31
80-. Ocular tumor management & it`s complication.12th
Iranian Congress of Optometry.
Naseripour M .18-20 August 2009. Tehran Razi Convention Center.
81- Uveal melanoma management : Lessons from cytogenetic profiling .
Naseripour M. 3rd
annual meeting of Iranian Retina Society. 22 Apr 2010 . Shiraz
82- Update on retinal disease and glaucoma: Panel discussion.
Naseripour M. 16th
annual meeting of TUMS Eye Research center 5-7 May 2010, Tehran
83-. The Role of cataract surgery in macular disease.
Naseripour M . 4th
annual meeting of IUMS Eye Research center, 21-23 july 2010 Tehran
84-. Approach to a fundus mass.
Naseripour M, ghasenmi F XXAnnual Congress of the Iran society of Ophthalmology 11-2
(1821آررها )
( هرخ 1فذش در بیواری اضتحال ابطت ب ضي شبکی ضویار یکرز زجاجی شبکی ) صاتفلرضا -85
دکتر هطعد اصری پر 11/16/21
86- Retinoblastoma Survival in Iran.
Naseripour M. SIOP Asia 2010, 3-5 March 2010 Kish Island
87- Surgical approach in Retinoblastoma.
Naseripour M. 6th
Congress of the SIOP Asia. March 3-5 2010, Iran-Kish Island
88- Ravindranath Y, Naseripour M, Epelman S, Vossough P.
6th
Congress of the SIOP Asia. Mrch 3-5 2010, Iran-Kish Island
89- Workshop: Approach to a fundus mass.
32
Naseripour M. XX Annual Congress of the Iranian Society of ophthalmology Nov.29- Dec.2,
2010
90- Differential diagnosis of an amelanotic fundus mass. XX Annual Congress of the Iranian
Society of ophthalmology Nov.29- Dec.2, 2010.
91- Approach to a fundus mass. Naseripour M. XX Annual Congress of the Iranian Society of
ophthalmology Nov.29- Dec.2, 2010.
92- Updates on managements of AMD. Naseripour M. XX Annual Congress of the Iranian
Society of ophthalmology Nov.29- Dec.2, 2010.
93- Salvage Ru-106 Plaque Radiotherapy after failed primary chemotherapy for advanced
Retinoblastoma . Naseripour M. XX Annual Congress of the Iranian Society of
ophthalmology Nov.29- Dec.2, 2010.
94-Trends in survival of Retinoblastoma patients in an ocular oncology unit in iran : 1991-2010.
Naseripour M. XX Annual Congress of the Iranian Society of ophthalmology Nov.29- Dec.2,
2010.
95-Controversies in vitreoretinal surgical techniques. (To Peal LIM? / Pros / Cons). Naseripour
M. XX Annual Congress of the Iranian Society of ophthalmology Nov.29- Dec.2, 2010.
96- Approach to a fundus mass. Naseripour M. XX Annual Congress of the Iranian Society of
ophthalmology Nov.29- Dec.2, 2010.
97- Approach to a fundus mass. Naseripour M. XX Annual Congress of the Iranian Society of
ophthalmology Nov.29- Dec.2, 2010.
33
؟ هی شد ARMD , DME جراحی کاتاراکت باعث تشذیذ بیواریای هاکال -12
دکتر رهضای –دکتر اشوی –دکتر کارخا –دکتر اصری پر
Controversies in ophthalmology 21-23 july 2010
99- EYELID.
Demerci H, Naseripour M.
Biannual Meeting ISOO 2011, 14-17 November.
100- Mystery case.
Naseripour M.
International society of ocular oncology, Biannual Meeting ISOO 2011, 14-17 November.
101- β-Radiation brachytherapy for large choroidal melanoma: Do we need A high dose
to the apex?
Naseripour M, falavarjani KG, Jaberi R, Irani AR, Azma Z.
International society of ocular oncology, Biannual Meeting ISOO 2011, 14-17
November.
102- Multidisciplinary coordinated services: what we need to improve in the management
of RB. Naseripour M, Nazari H, Falavarjani KG, Soudi R, Maleki A, Ansari S.
International society of ocular oncology, Biannual Meeting ISOO 2011, 14-17 November.
103- Central serous chorioretinophaty.
Controversies in ophthalmology 20-22 july 2011.
104- Results of the Comparison of AMD Treatment Trials (CATT Study).
Shahid Beheshti University of Medical Sciences. February 1-3, 2012.
34
105-Moderator of Oncology session in WOC.
Hind Alkatan, Santosh Honavar, Naseripour M, Jacob pe`er, Jerry Shields.
12th
MEACO International Congress.16-20 February 2012, Abu Dhabi, United Arab
Emirates.
106- Miscellaneous Tumors / Photodynamic therapy (PDT): is it an effective treatment
modality for retinal and choroidal vascular Tumors?
Naseripour M .12th
MEACO International Congress.16-20 February 2012, Abu Dhabi,
United Arab Emirates.
107- Jerry Slields, Naseripour M. Rapid Fire papers: chairpersons.
12th
MEACO International Congress.16-20 February 2012, Abu Dhabi, United Arab
Emirates.
108 - Rapid Fire papers: Mystery Case. Naseripour M
12th
MEACO International Congress.16-20 February 2012, Abu Dhabi, United Arab
Emirates.
109- Vitreoretinal considerations in cataract surgery. (Vitreoretinal interface changes after
cataract surgery (OCT Findings)). Naseripour M
، هحود آباد هازذراى 1811اردیبشت 11تا 16جذویي ضویار ضالیا فارابی، پیذ قری کاتاراکت،
110- Ocular pathology & tumors 3. Uveal Nevus. APAO/SOE Busan 2012, 13-16 April
2012. Naseripour M. Bexco, Busan, Korea.
111- Invited lecturer by Visual Sciences groups. Chaharshanbe-Soori Injuries Forum.
Naseripour M.
ضویار فارابی 1811اضفذ ها 16 11
35
112- Nine Novel RBI Mutation and Genotype/ Phenotype Correlation in Patients with
Retinoblastoma Referred to Rassoul Akram Hospital. Naseripour M.
ضویار فارابی 1811اضفذ ها 16 11
113- Naseripour M. Update in Retinoblastoma
رشت-کارزیبا 1811ها خرداد 16 11
114- Naseripour M. How far do you continue the treatment in exudative ARMD?
Controversies in ophthalology .Eye Research Center,Rassoul Akram Hospital,Tehran
Unversity of Medical Sciences. 11-13 jul 2012.
115- Symposium: Retina Disease (Part1), (Results of the comparison of AMD Treatment
Trials (CATT Study)): Naseripour M . Advances and innovations in ophthalmology.
7th
Annual Meeting of the Ophthalmic Research Center. Shahid beheshti University
of Medical Sciences. February 1-3, 2012.
116- Vitreoretinal considerations in cataract surgery. (Vitreoretinal interface changes after
cataract surgery (OCT Findings)). Masood Naseripour. هجدهمیه سمیىار سالیاوه فارابی، پیىود
, قرویه و کاتاراکت محمىد آباد مازودران . 2932اردیبهشت 21 تا 21
117- Naseripour Masood,Live surgery Performed in XXII Annual Congress Of The
Iranian Society Of Ophthalmology ,30 oct2012.
118- Naseripour Masood,Free Papers:Posterior Segment, Moderated in XXII Annual
Congress Of The Iranian Society Of Ophthalmology ,31oct2012.
119- Naseripour Masood,Temporary Keratoprosthesis:TPK,K-pro..Video Presented in
posterior Segment Trauma Workshop in XXII Annual Congress Of The Iranian Society Of
Ophthalmology ,1nov2012
36
120- Naseripour Masood,Genotype – Phenotype Correlation in Iranian Patients with
Retinoblastoma, Oral Presentation in XXII Annual Congress Of The Iranian Society Of
Ophthalmology ,1nov2012.
121- Naseripour Masood,The Trend in the Survival of the Patient with Retinoblastoma,
Poster Presentation in XXII Annual Congress Of The Iranian Society Of Ophthalmology
,1nov2012.
122- Nasseripour Masoud, The Chair of Free Paper, IRAVO Congress, 7march 2013
123- Nasseripour Masoud,Genotype-Phenotype Correlation in Iranian Patients with
Retinoblastoma,Oral Presentation in IRAVO Congress, 8march 2013
براه فق تخصصی گر دکتر هطعد اصری پر. ریکرد ب ضایعات پیگوات فذش. ارائ در -164
زدویي ضیار ضالیا فارابی ششویي گردوایی گر فق رتیي: ریکرد ب بیواریای یتر رتیي.
وىزدهمیه سیىار .1816اردیبشت 1تخصصی یتر رتیي اجوي چشن پسشکی ایراى،تراى ،تل الوپیک ،
سالیاوه فارابی
ویت پص از در ضوپزیم : اذفتال ارائ دکتر هطعد اصری پر. اذفتالویت پص از جراحی کاتاراکت . -161
جراحی کاتاراکت. زدویي ضیار ضالیا فارابی ششویي گردوایی گر فق تخصصی یتر رتیي اجوي
وىزدهمیه سیىار سالیاوه فارابی .1816اردیبشت 2چشن پسشکی ایراى،تراى ،تل الوپیک ،
126- Nasseripour Masoud, Controversies in the management of retinal vein occlusion
127-Naseripour Masood, Workshop: Approach to Intraocular Tumors. Moderated in 23th
Annual Congress of The Iranian Society of Ophthalmology. Tuesday, 29 October.
37
128- Naseripour Masood, Workshop: Approach to Intraocular Tumors. Approach to
Pigmented Intraocular Tumors. Presented in 23th
Annual Congress of The Iranian Society of
Ophthalmology. Tuesday, 29 October.
129- Naseripour Masood, Workshop: Approach to Intraocular Tumors. Presented in 23th
Annual Congress of The Iranian Society of Ophthalmology. Tuesday, 29 October.
یچشن پسشک ایضال شیوا يیدر کدکاى. ارائ شذ در ششو عیشا یچشو ی، تهر اپىر یمسعىد واصر -181
، زاذاى .1816اضفذ 2زاذاى. پج شب یداشگا علم پسشک
چشن ایضال شیوا يیارائ شذ در ششودرهاى تهرای چشوی در کدکاى. ، پىر یمسعىد واصر -292
challenging caseرضا اضذی، ، زاذاى .1816اضفذ 2زاذاى. پج شب یداشگا علم پسشک یپسشک
in exotropia .زاذاى یداشگا علم پسشک یچشن پسشک ایضال شیوا يیارائ شذ در ششو
38
132- Indications and Limitations of Fundus Imaging Techniques, Ultrasonography, Presented
in WOC 2014, 4 April,Tokyo by Masood Naseripour . Invited Speaker
133- Uveal Melanoma: Trends in Management, Moderated by Masood Naseripour, WOC 2014, 4
April,Tokyo.
134- The Role of TTT, PDT and Anti VEG-F Treatment in Uveal Melanoma, , Presented in
WOC 2014, 4 April, Tokyo by Masood Naseripour. Invited Speaker
135- Naseripour Masood, Retina Subspecialty Day, New Concepts in Vitreoretinal
Surgeries, Moderated in XXIV Annual Congress of The Iranian Society of Ophthalmology,
Monday, December 01 , 2014, Razi Convention Center, Tehran.
136- Naseripour Masood, Keynote Lecture. Moderated in XXIV Annual Congress of
The Iranian Society of Ophthalmology, Thursday, December 04 , 2014, Razi Convention
Center, Tehran.
137- Naseripour Masood, Lunch Meeting : Ophthalmology Residency Training in
Europe , USA, IRAN. Panel Discussion. Moderated in XXIV Annual Congress of The
Iranian Society of Ophthalmology, Thursday, December 04 , 2014, Razi Convention Center,
Tehran.
138- Naseripour Masood, Workshop : Ocular Oncology. Moderated in XXIV Annual
Congress of The Iranian Society of Ophthalmology, Thursday, December 04 , 2014,
Razi Convention Center, Tehran.
139-Naseripour Masood, Moderator of Free Paper 7 in in 5th IRAVO Seminar , 6 March
2015, Razi Convention Center, Tehran.
39
140-Naseripour Masood, Pediatric Ocular trauma 21th
Farabi Annual Meeting
6-8 May 2015 Olympic Hotel ,Tehran, Iran
141-Naseripour Masood, Retina Updates Symposium: Updates of intraocular melanoma.
Presented in 10th Annual Seminar of Advances and Innovations in
Ophthalmology,Thursday, 29 January 2015, Razi Convention Center, Tehran
142-Naseripour Masood, Workshop : Ocular Oncology, Melanoma and
Pseudomelanoma. Presented in XXIV Annual Congress of The Iranian Society of
Ophthalmology, Thursday, December 04 , 2014, Razi Convention Center, Tehran.
143- Naseripour Masood, Workshop : Ocular Oncology, Case Presentation. Presented in
XXIV Annual Congress of The Iranian Society of Ophthalmology, Thursday,
December 04 , 2014, Razi Convention Center, Tehran.
144- Naseripour Masoud, Workshop of Approach to Open Globe Injury, Case
Presentation. Presented in 20th
Farabi Annual Meeting, 30 April- 2 May 2014
Olympic Hotel ,Tehran, Iran.
145- Naseripour Masoud, Management of a Fundus Mass in Elderly: Follow Up versus
Intervention . 9th
contraversis in ophthalmology , july 2015 29-31. (Moderator)
40
146-Naseripour Masood. Updates of diabetic retinopathy. 8th vitreoretinal subspecialty day, Isfahan
April 2015
147-Naseripour Masood. AMD. 8th vitreoretinal subspecialty day, Isfahan April 2015
جراحي در تهراي هلتحو. تاز اي تهراي هلتحو ضوائن بیوارضتاى ى دكتر اصري پر. درها - 142
5/6/14فارابي
149) Masood Naseripour: Retina Subspecialty day. Updates on Genetic Studies in
Ocular Tumors.
XXIV Annual Congress of The Iranian Society of Ophthalmology, Monday, December 14
, 2015, Razi Convention Center, Tehran.
150) Masood Naseripour, Fariba Ghasemi, Ahad Sedaghat. Workshop: Fundus
Mass : What to do?
XXIV Annual Congress of The Iranian Society of Ophthalmology, Thursday, December
17 , 2015, Razi Convention Center, Tehran.
151) Masood Naseripour, Invited Speaker,Tips and Tricks in A&B Ultrasound in
Diagnosis and Management of Intraocular Tumors, World Ophthalmology Congress 2016
(WOC2016), February 5-9, 2016 , Guadalajara, Mexico
152) Masood Naseripour, Invited Speaker, Peripapillary Cavernous Hemangioma, World
Ophthalmology Congress 2016 (WOC2016), February 5-9, 2016 , Guadalajara, Mexico
153) Ophthalmology Updates 27-29 April 2016, Farabi Annual Meeting
- Current State of Therapeutic Strategies in Age Related Macular
Degeneration(AMD) Panel Discussion, Panel Discussion,Interactive Case
Presentation, April 27, 2016 , 09:00 - 10:00
154) Ophthalmology Updates 27-29 April 2016, Farabi Annual Meeting
- Workshop: Case Presentations of Ocular Trauma, April 29, 2016, 11:00 - 13:00
41
155- Vitreoretinal interface abnormality symposiom : Pneumatic and
pharmacologic vireolysis April 21 2016 kermanshah
156- First spring ophthalmology meeting 11-14 April 2017
Workshop: Update on retinal degenerations. 11 Apr 2017 12:00-13:00
Workshop: controversies in approach to a fundus mass. 12 Apr 2017 14:30-15:30
Moderator: Update on retinal degenerations. 11 Apr 2017 12:00-13:00
Panel Discussion: Controversies in approach to treatment of ARMD. 12 Apr 2017 11:00-
12:00
Panel Discussion: Controversies in approach to fundus mass. 12 Apr 2017 14:30-15:30
Workshop: neurodegenerative changes in DR. 13 Apr 2017 9:20-9:30
157-Farabi Annual Meeting. Ophthalmology updates 26-8 April 2017.
Workshop: Challenging Cases of Ocular Trauma and Emergency 14:00-15:30
Moderator: Challenging Cases of Ocular Trauma and Emergency 14:00-15:30
Workshop: diabetic retinopathy: interactive case presentation and panel discussion 9:15-10:30
158- West Asia Cancer Conference Scientific Agenda. 1 Dec. 2017 2nd
Day
Moderators: Oculo-Facial Cancers
Speaker: Choroidal Metastasis: Incidence, Clinical Features and Management
159- XXVII Annual Congress of the Iranian Society of Ophthalmology. 4-7 dec 2017
Moderator: Workshop: Differential Diagnosis of Intraocular Masses 16:30 - 18:00 7 Dec
Speaker: Primary Versus Secondary Intraocular Tumors 17:16 - 17:30 7 Dec
Case Presentation: 17:46 - 18:00 7 Dec
Moderator: Retina Subspecialty Day: Updates on Pediatric Retina / Update on Retinal Imaging
10:30 - 12:30 4 Dec
42
Speaker: Updates on Retinal Imaging. 11:30 - 12:30 4 Dec
Moderator: 2017 Young Ophthalmologist Programs , Strabismus / Retina 14:30 - 16:00 4 Dec
Speaker: 2017 Young Ophthalmologist Programs , Retina 15:15 - 16:00 4 Dec
160- West Asia cancer conference (WACC) 2017- 9-11 – dr.Naseripour